{
    "organizations": [],
    "uuid": "b79727a8c95aa2060e33862131bfeaf7a1730ad5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ironwood-pharmaceuticals-to-separa/brief-ironwood-pharmaceuticals-to-separate-into-two-independent-publicly-traded-companies-idUSASC09YKD",
    "ord_in_thread": 0,
    "title": "BRIEF-Ironwood Pharmaceuticals To Separate Into Two Independent, Publicly Traded Companies",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1 (Reuters) - Ironwood Pharmaceuticals Inc:\n* IRONWOOD PHARMACEUTICALS ANNOUNCES INTENT TO SEPARATE SOLUBLE GUANYLATE CYCLASE (SGC) BUSINESS FROM COMMERCIAL AND GASTROINTESTINAL BUSINESS\n* IRONWOOD PHARMACEUTICALS INC - SEPARATION EXPECTED TO RESULT IN TWO INDEPENDENT, PUBLICLY TRADED COMPANIES\n* IRONWOOD PHARMACEUTICALS INC - EXPECTS TO INCUR CHARGES RELATED TO TRANSACTION\n* IRONWOOD - ASSETS EXPECTED TO CONTINUE TO INCLUDE THREE IN-MARKET PRODUCTS AND TWO DEVELOPMENT CANDIDATES TARGETING GI DISEASES AND ABDOMINAL PAIN\n* IRONWOOD - ANTICIPATES BEING PROFITABLE WITH “STRONG REVENUE GROWTH” FROM ITS IN-MARKET PRODUCTS FOLLOWING SEPARATION\n* IRONWOOD PHARMACEUTICALS INC - PLANS TO HAVE SEPARATE BOARDS AND MANAGEMENT TEAMS FOR EACH BUSINESS\n* IRONWOOD - ALL OF IRONWOOD’S CURRENT LINACLOTIDE COLLABORATIONS ARE EXPECTED TO REMAIN WITH IRONWOOD\n* IRONWOOD PHARMACEUTICALS INC - INTENDS TO TRANSITION EMPLOYEES TO NEW BUSINESSES AS ORGANIZATION DESIGN IS COMPLETED OVER COMING MONTHS\n* IRONWOOD PHARMA - PLANS TO PROVIDE UPDATE ON IMPACT OF TRANSACTION CHARGES ON 2018 GUIDANCE DURING Q2 INVESTOR UPDATE\n* IRONWOOD PHARMACEUTICALS INC - IRONWOOD EXPECTED TO RETAIN U.S. RIGHTS TO LESINURAD FRANCHISE FOR UNCONTROLLED GOUT\n* IRONWOOD PHARMACEUTICALS INC - AFTER SEPARATION, COMMERCIAL BUSINESS TO CONTINUE TO BE NAMED IRONWOOD, NAME OF RESEARCH AND DEVELOPMENT CO. TO BE ANNOUNCED LATER Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-01T20:03:00.000+03:00",
    "crawled": "2018-05-02T16:17:54.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "ironwood",
        "pharmaceutical",
        "inc",
        "ironwood",
        "pharmaceutical",
        "announces",
        "intent",
        "separate",
        "soluble",
        "guanylate",
        "cyclase",
        "sgc",
        "business",
        "commercial",
        "gastrointestinal",
        "business",
        "ironwood",
        "pharmaceutical",
        "inc",
        "separation",
        "expected",
        "result",
        "two",
        "independent",
        "publicly",
        "traded",
        "company",
        "ironwood",
        "pharmaceutical",
        "inc",
        "expects",
        "incur",
        "charge",
        "related",
        "transaction",
        "ironwood",
        "asset",
        "expected",
        "continue",
        "include",
        "three",
        "product",
        "two",
        "development",
        "candidate",
        "targeting",
        "gi",
        "disease",
        "abdominal",
        "pain",
        "ironwood",
        "anticipates",
        "profitable",
        "strong",
        "revenue",
        "growth",
        "product",
        "following",
        "separation",
        "ironwood",
        "pharmaceutical",
        "inc",
        "plan",
        "separate",
        "board",
        "management",
        "team",
        "business",
        "ironwood",
        "ironwood",
        "current",
        "linaclotide",
        "collaboration",
        "expected",
        "remain",
        "ironwood",
        "ironwood",
        "pharmaceutical",
        "inc",
        "intends",
        "transition",
        "employee",
        "new",
        "business",
        "organization",
        "design",
        "completed",
        "coming",
        "month",
        "ironwood",
        "pharma",
        "plan",
        "provide",
        "update",
        "impact",
        "transaction",
        "charge",
        "guidance",
        "q2",
        "investor",
        "update",
        "ironwood",
        "pharmaceutical",
        "inc",
        "ironwood",
        "expected",
        "retain",
        "right",
        "lesinurad",
        "franchise",
        "uncontrolled",
        "gout",
        "ironwood",
        "pharmaceutical",
        "inc",
        "separation",
        "commercial",
        "business",
        "continue",
        "named",
        "ironwood",
        "name",
        "research",
        "development",
        "announced",
        "later",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}